Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2002 Nov;73(5):568–573. doi: 10.1136/jnnp.73.5.568

Central motor conduction in patients with anti-ganglioside antibody associated neuropathy syndromes and hyperreflexia

Y Oshima 1, T Mitsui 1, H Yoshino 1, I Endo 1, M Kunishige 1, A Asano 1, T Matsumoto 1
PMCID: PMC1738137  PMID: 12397153

Abstract

Objectives: Several serum antibodies against gangliosides are diagnostically important, particularly in Guillain-Barré syndrome (GBS), Miller Fisher syndrome (MFS), and multifocal motor neuropathy (MMN). Although hyperreflexia is an atypical symptom in these disorders, it has been found in some patients with GBS, MFS, and MMN. The aim of the study was to determine whether hyperreflexia corresponds to corticospinal tract dysfunction in these patients.

Methods: The study examined central and peripheral motor conduction in patients with hyperreflexia who exhibited acute paralysis (group 1, n=5), acute ataxia and ophthalmoplegia (group 2, n=7), or chronic paralysis with conduction block (group 3, n=2). The clinical symptoms are similar to those in patients with GBS, MFS, and MMN, respectively, and serum anti-ganglioside antibodies were found to be positive in all patients. Using magnetic and electrical stimulation techniques, central and peripheral motor conduction were compared in patients in groups 1, 2, and 3 and patients with GBS (n=7), MFS (n=8), and MMN (n=6).

Results: Central motor conduction times (CMCTs) in patients in groups 1, 2, and 3 were significantly delayed compared with those in patients with GBS, MFS, and MMN (p<0.01, p<0.05, p<0.05, respectively), and the delayed CMCTs significantly improved in the recovery periods (p<0.01, p<0.01, p<0.05, respectively). However, motor conduction velocity, compound muscle action potential, and F wave conduction velocity were not significantly different between the patients.

Conclusion: These findings indicate that corticospinal tract is functionally involved in patients with anti-ganglioside antibody associated neuropathy syndromes and hyperreflexia

Full Text

The Full Text of this article is available as a PDF (174.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Din A. N., Anderson M., Bickerstaff E. R., Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982 Sep;105(Pt 3):481–495. doi: 10.1093/brain/105.3.481. [DOI] [PubMed] [Google Scholar]
  2. Asbury A. K., Cornblath D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S21–S24. doi: 10.1002/ana.410270707. [DOI] [PubMed] [Google Scholar]
  3. Bouche P., Moulonguet A., Younes-Chennoufi A. B., Adams D., Baumann N., Meininger V., Léger J. M., Said G. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):38–44. doi: 10.1136/jnnp.59.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997 Jan 16;745(1-2):32–36. doi: 10.1016/s0006-8993(96)01123-7. [DOI] [PubMed] [Google Scholar]
  5. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  6. Corse A. M., Chaudhry V., Crawford T. O., Cornblath D. R., Kuncl R. W., Griffin J. W. Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol. 1996 Mar;39(3):319–325. doi: 10.1002/ana.410390308. [DOI] [PubMed] [Google Scholar]
  7. FISHER M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956 Jul 12;255(2):57–65. doi: 10.1056/NEJM195607122550201. [DOI] [PubMed] [Google Scholar]
  8. Hadden R. D., Cornblath D. R., Hughes R. A., Zielasek J., Hartung H. P., Toyka K. V., Swan A. V. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998 Nov;44(5):780–788. doi: 10.1002/ana.410440512. [DOI] [PubMed] [Google Scholar]
  9. Hao Q., Saida T., Yoshino H., Kuroki S., Nukina M., Saida K. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann Neurol. 1999 Jun;45(6):758–768. [PubMed] [Google Scholar]
  10. Honavar M., Tharakan J. K., Hughes R. A., Leibowitz S., Winer J. B. A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. Brain. 1991 Jun;114(Pt 3):1245–1269. doi: 10.1093/brain/114.3.1245. [DOI] [PubMed] [Google Scholar]
  11. Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D., Griffin D. E., Griffin J. W., McKhann G. M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol. 1988 May;23(5):440–447. doi: 10.1002/ana.410230503. [DOI] [PubMed] [Google Scholar]
  12. Kornberg A. J., Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol. 1995 May;37 (Suppl 1):S43–S50. doi: 10.1002/ana.410370706. [DOI] [PubMed] [Google Scholar]
  13. Krarup C., Stewart J. D., Sumner A. J., Pestronk A., Lipton S. A. A syndrome of asymmetric limb weakness with motor conduction block. Neurology. 1990 Jan;40(1):118–127. doi: 10.1212/wnl.40.1.118. [DOI] [PubMed] [Google Scholar]
  14. Kuwabara S., Ogawara K., Koga M., Mori M., Hattori T., Yuki N. Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):180–184. doi: 10.1136/jnnp.67.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol. 1998 Aug;44(2):202–208. doi: 10.1002/ana.410440210. [DOI] [PubMed] [Google Scholar]
  16. McKhann G. M., Cornblath D. R., Griffin J. W., Ho T. W., Li C. Y., Jiang Z., Wu H. S., Zhaori G., Liu Y., Jou L. P. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993 Apr;33(4):333–342. doi: 10.1002/ana.410330402. [DOI] [PubMed] [Google Scholar]
  17. McKhann G. M., Cornblath D. R., Ho T., Li C. Y., Bai A. Y., Wu H. S., Yei Q. F., Zhang W. C., Zhaori Z., Jiang Z. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet. 1991 Sep 7;338(8767):593–597. doi: 10.1016/0140-6736(91)90606-p. [DOI] [PubMed] [Google Scholar]
  18. Miwa H., Imamura N., Kogahara K., Ohori T., Mizuno Y. Somatosensory evoked blink response: findings in patients with Miller Fisher syndrome and in normal subjects. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):95–99. doi: 10.1136/jnnp.58.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Molinuevo J. L., Cruz-Martínez A., Graus F., Serra J., Ribalta T., Valls-Solé J. Central motor conduction time in patients with multifocal motor conduction block. Muscle Nerve. 1999 Jul;22(7):926–932. doi: 10.1002/(sici)1097-4598(199907)22:7<926::aid-mus17>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  20. Nobile-Orazio E., Meucci N., Barbieri S., Carpo M., Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology. 1993 Mar;43(3 Pt 1):537–544. doi: 10.1212/wnl.43.3_part_1.537. [DOI] [PubMed] [Google Scholar]
  21. Nobile-Orazio E. Multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):599–603. doi: 10.1136/jnnp.60.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oshima Y., Mitsui T., Endo I., Umaki Y., Matsumoto T. Corticospinal tract involvement in a variant of Guillain-Barré syndrome. Eur Neurol. 2001;46(1):39–42. doi: 10.1159/000050754. [DOI] [PubMed] [Google Scholar]
  23. Pestronk A., Choksi R. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology. 1997 Nov;49(5):1289–1292. doi: 10.1212/wnl.49.5.1289. [DOI] [PubMed] [Google Scholar]
  24. Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W., Alderson K., Adams R. N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73–78. doi: 10.1002/ana.410240113. [DOI] [PubMed] [Google Scholar]
  25. Pestronk A. Multifocal motor neuropathy: diagnosis and treatment. Neurology. 1998 Dec;51(6 Suppl 5):S22–S24. doi: 10.1212/wnl.51.6_suppl_5.s22. [DOI] [PubMed] [Google Scholar]
  26. Petty R. K., Duncan R., Jamal G. A., Hadley D., Kennedy P. G. Brainstem encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):201–203. doi: 10.1136/jnnp.56.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rees J. H., Gregson N. A., Hughes R. A. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995 Nov;38(5):809–816. doi: 10.1002/ana.410380516. [DOI] [PubMed] [Google Scholar]
  28. Ropper A. H. The Guillain-Barré syndrome. N Engl J Med. 1992 Apr 23;326(17):1130–1136. doi: 10.1056/NEJM199204233261706. [DOI] [PubMed] [Google Scholar]
  29. Schulte-Mattler W. J., Müller T., Zierz S. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999 Nov 15;170(1):51–56. doi: 10.1016/s0022-510x(99)00201-4. [DOI] [PubMed] [Google Scholar]
  30. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yoshino H., Harukawa H., Asano A. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy. J Neuroimmunol. 2000 Jun 26;105(2):195–201. doi: 10.1016/s0165-5728(99)00280-5. [DOI] [PubMed] [Google Scholar]
  32. Yuki N., Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol. 1998 Apr;43(4):546–547. doi: 10.1002/ana.410430424. [DOI] [PubMed] [Google Scholar]
  33. Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 1993 Aug;118(1):83–87. doi: 10.1016/0022-510x(93)90250-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES